270 related articles for article (PubMed ID: 31475596)
1. Glycoconjugate vaccines: current approaches towards faster vaccine design.
Micoli F; Del Bino L; Alfini R; Carboni F; Romano MR; Adamo R
Expert Rev Vaccines; 2019 Sep; 18(9):881-895. PubMed ID: 31475596
[No Abstract] [Full Text] [Related]
2. Synthetic carbohydrate-based vaccines: challenges and opportunities.
Mettu R; Chen CY; Wu CY
J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
[TBL] [Abstract][Full Text] [Related]
3. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production.
Dow JM; Mauri M; Scott TA; Wren BW
Expert Rev Vaccines; 2020 Jun; 19(6):507-527. PubMed ID: 32627609
[TBL] [Abstract][Full Text] [Related]
4. [Carbohydrates and vaccines: from purified polysaccharides to semi-synthetic glycoconjugate vaccines].
Mulard L
Ann Pharm Fr; 2007 Jan; 65(1):14-32. PubMed ID: 17299349
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification.
Berti F; Adamo R
Chem Soc Rev; 2018 Dec; 47(24):9015-9025. PubMed ID: 30277489
[TBL] [Abstract][Full Text] [Related]
6. Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines.
Adamo R
Acc Chem Res; 2017 May; 50(5):1270-1279. PubMed ID: 28463499
[TBL] [Abstract][Full Text] [Related]
7. Improving vaccines against
Kaplonek P; Khan N; Reppe K; Schumann B; Emmadi M; Lisboa MP; Xu FF; Calow ADJ; Parameswarappa SG; Witzenrath M; Pereira CL; Seeberger PH
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):13353-13358. PubMed ID: 30530654
[No Abstract] [Full Text] [Related]
8. Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design.
Terra VS; Mills DC; Yates LE; Abouelhadid S; Cuccui J; Wren BW
J Med Microbiol; 2012 Jul; 61(Pt 7):919-926. PubMed ID: 22516134
[TBL] [Abstract][Full Text] [Related]
9. Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs.
Berti F; Micoli F
Curr Opin Immunol; 2020 Aug; 65():42-49. PubMed ID: 32361591
[TBL] [Abstract][Full Text] [Related]
10. Potential targets for next generation antimicrobial glycoconjugate vaccines.
Micoli F; Costantino P; Adamo R
FEMS Microbiol Rev; 2018 May; 42(3):388-423. PubMed ID: 29547971
[TBL] [Abstract][Full Text] [Related]
11. Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation.
Nilo A; Morelli L; Passalacqua I; Brogioni B; Allan M; Carboni F; Pezzicoli A; Zerbini F; Maione D; Fabbrini M; Romano MR; Hu QY; Margarit I; Berti F; Adamo R
ACS Chem Biol; 2015 Jul; 10(7):1737-46. PubMed ID: 25906283
[TBL] [Abstract][Full Text] [Related]
12. Chemical Synthesis of Rare, Deoxy-Amino Sugars Containing Bacterial Glycoconjugates as Potential Vaccine Candidates.
Behera A; Kulkarni SS
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103434
[TBL] [Abstract][Full Text] [Related]
13. Semi- and fully synthetic carbohydrate vaccines against pathogenic bacteria: recent developments.
Zasłona ME; Downey AM; Seeberger PH; Moscovitz O
Biochem Soc Trans; 2021 Nov; 49(5):2411-2429. PubMed ID: 34495299
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in lipopolysaccharide-based glycoconjugate vaccines.
Zhu H; Rollier CS; Pollard AJ
Expert Rev Vaccines; 2021 Dec; 20(12):1515-1538. PubMed ID: 34550840
[TBL] [Abstract][Full Text] [Related]
15. Direct Cloning of Bacterial Surface Polysaccharide Gene Cluster for One-Step Production of Glycoconjugate Vaccine.
Ma Z; Zhang H; Li L; Chen M; Wang PG
ACS Infect Dis; 2019 Jan; 5(1):74-78. PubMed ID: 30445812
[TBL] [Abstract][Full Text] [Related]
16. Glycoconjugate vaccines: classic and novel approaches.
Adamo R
Glycoconj J; 2021 Aug; 38(4):397-398. PubMed ID: 34169357
[TBL] [Abstract][Full Text] [Related]
17. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
[TBL] [Abstract][Full Text] [Related]
19. Classical and novel strategies to develop a
Barel LA; Mulard LA
Hum Vaccin Immunother; 2019; 15(6):1338-1356. PubMed ID: 31158047
[No Abstract] [Full Text] [Related]
20. Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends.
Micoli F; Adamo R; Costantino P
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
